Not Yet Recruiting
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.
NCT07528898
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China